Genome-wide TDT analysis in French-Canadian families with tourette syndrome

Canadian Journal of Neurological Sciences

Volumn 37, Issue 1, 2010, Pages 110-112

  Rivière, Jean Baptiste ^a   St Onge, Judith ^a   Gaspar, Claudia ^a   Diab, Sabrina ^a   Dion, Yves ^a   Lespérance, Paul ^a   Tellier, Geneviève ^b   Richer, François ^c   Chouinard, Sylvain ^a   Dubé, Marie Pierre ^d   Rouleau, Guy A ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^d MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANAMNESIS; ARTICLE; ATTENTION DEFICIT DISORDER; AUTOSOME; CLINICAL EVALUATION; COMORBIDITY; DISEASE PREDISPOSITION; FAMILY STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOME ANALYSIS; GENOTYPE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MALE; MICROSATELLITE MARKER; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PROGENY; X CHROMOSOME;

EID: 76649134096     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100009744     Document Type: Article

References (25)

1. Robertson MM. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. JPsychosom Res. 2008;65(5):461-472
2. Definitions and classification of tic disorders. The Tourette Syndrome Classification Study Group. Arch Neurol. 1993;50 (10):1013-1016
3. Peterson BS, Pine DS, Cohen P, Brook JS. Prospective, longitudinal study of tic, obsessive-compulsive, and attention-deficit/ hyperactivity disorders in an epidemiological sample. JAm Acad Child Adolesc Psychiatry. 2001;40(6):685-695
4. Robertson MM. Tourette syndrome, associated conditions and the complexities of treatment. Brain. 2000;123(Pt 3):425-462
5. Pauls DL, Cohen DJ, Heimbuch R, Detlor J, Kidd KK. Familial pattern and transmission of Gilles de la Tourette syndrome and multiple tics. Arch Gen Psychiatry. 1981;38(10):1091-1093
6. Price RA, Kidd KK, Cohen DJ, Pauls DL, Leckman JF. A twin study of Tourette syndrome. Arch Gen Psychiatry. 1985;42(8):815-820
7. Gade R, Muhleman D, Blake H, MacMurray J, Johnson P, Verde R, et al. Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse. Mol Psychiatry. 1998;3(1):50-60.
8. Grice DE, Leckman JF, Pauls DL, Kurlan R, Kidd KK, Pakstis AJ, et al. Linkage disequilibrium between an allele at the dopamine D4 receptor locus and Tourette syndrome, by the transmissiondisequilibrium test. Am JHum Genet. 1996;59(3):644-652
9. Diaz-Anzaldua A, Joober R, Riviere JB, Dion Y, Lesperance P, Richer F, et al. Tourette syndrome and dopaminergic genes: a family-based association study in the French Canadian founder population. Mol Psychiatry. 2004;9(3):272-277
10. Brett PM, Curtis D, Robertson MM, Gurling HM. Exclusion of the 5-HT1A serotonin neuroreceptor and tryptophan oxygenase genes in a large British kindred multiply affected with Tourette's syndrome, chronic motor tics, and obsessive-compulsive behavior. Am JPsychiatry . 1995;152(3):437-440
11. Hebebrand J, Nothen MM, Ziegler A, Klug B, Neidt H, Eggermann K, et al. Nonreplication of linkage disequilibrium between the dopamine D4 receptor locus and Tourette syndrome. Am JHum Genet. 1997;61(1):238-239
12. Comings DE, Gonzalez N,Wu S, Gade R, Muhleman D, Saucier G, et al. Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. Am JM ed Genet. 1999;88(4):358-368
13. Varilo T, Peltonen L. Isolates and their potential use in complex gene mapping efforts. Curr Opin Genet Dev. 2004;14(3):316-323
14. Lesage S, Durr A, Tazir M, Lohmann E, Leutenegger AL, Janin S, et al. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl JMed. 2006;354(4):422-423
15. Ozelius LJ, Senthil G, Saunders-Pullman R, Ohmann E, Deligtisch A, Tagliati M, et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med. 2006;354(4):424-425
16. Tonin PN, Mes-Masson AM, Futreal PA, Morgan K, Mahon M, Foulkes WD, et al. Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am JHum Genet. 1998;63(5):1341-1351
17. Heyer E, Tremblay M. Variability of the genetic contribution of Quebec population founders associated to some deleterious genes. Am JHum Genet. 1995;56(4):970-978
18. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006-1011
19. Laird NM, Horvath S, Xu X. Implementing a unified approach to family-based tests of association. Genet Epidemiol. 2000;19 Suppl 1:S36-42.
20. Rabinowitz D, Laird N. A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum Hered. 2000;50(4):211-223
21. Horvath S, Xu X, Laird NM. The family based association test method: strategies for studying general genotype--phenotype associations. Eur JHum Genet. 2001;9(4):301-306
22. Chen WM, Deng HW. A general and accurate approach for computing the statistical power of the transmission disequilibrium test for complex disease genes. Genet Epidemiol. 2001;21(1):53-67.
23. A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. The Tourette Syndrome Association International Consortium for Genetics. Am JHum Genet. 1999;65(5):1428-1436
24. Genome scan for Tourette disorder in affected-sibling-pair and multigenerational families.Am JHum Genet. 2007;80(2):265-272
25. McMahon WM, van de Wetering BJ, Filloux F, Betit K, Coon H, Leppert M. Bilineal transmission and phenotypic variation of Tourette's disorder in a large pedigree. JAm Acad Child Adolesc Psychiatry. 1996;35(5):672-680